Golidocitinib Pilot Study in Mycosis Fungoides and T-LGLL Initiated
A pilot study of golidocitinib is enrolling patients with advanced-stage mycosis fungoides/Sézary syndrome and T-cell large granular lymphocytic leukemia.
Therapeutic Area
Therapeutic area intelligence for T-cell malignancies with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.